{"id":"b8e1f19c-ef9f-4d5d-9c26-b2181ea3de76","kind":"institutions","code":"UB-I8645","name":"Hongyi Capital","nameBasis":"transliterated","summary":"Hongyi Capital, a private equity investment firm focused on healthcare.","description":"Hongyi Capital, a private equity investment firm focused on healthcare.","country":null,"category":null,"originalName":"弘毅资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:28:22.433Z","englishUpdatedAt":"2026-10-15T17:35:39.635Z","reviewedAt":"2026-10-15T17:35:39.635Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"ffd349b8aa041f772b04d9aa27561d787dd573f963995912d986b4fab47492b7","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"弘毅资本，从事私募股权投资的投资机构，关注医疗健康。","sources":[],"related":[{"id":"48c7fbb5-da1d-4d8f-8891-16287b8388df","kind":"news","code":"48c7fbb5-da1d-4d8f-8891-16287b8388df","name":"iRegene raises RMB 260 million in Series C+ financing","nameBasis":"translated-title","summary":"On 2026-07-02, according to Xiniu Data, iRegene completed Series C+ financing, raising RMB 260 million. Investors were lead investor Chengdu Ke Venture Capital, participating investor Zhongxinjian Investment Ben, participating investor Xi Venture Capital, participating investor Dingtaixing, participating investor Xinjiye, participating investor Hongyi Capital, participating investor Yuanxihaihe (Tianjin) Biotechnology Pharmaceutical Industry Fund Partnership (Limited Partnership). The company is a developer of chemically induced cell therapy drugs.","description":"","country":null,"category":null,"originalName":"睿健医药完成C+融资，金额2.60亿人民币","eventDate":"2026-07-02T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T17:18:19.314Z","englishUpdatedAt":"2026-10-15T19:44:30.495Z","reviewedAt":"2026-10-15T19:44:30.495Z","snapshotAt":"2026-10-15T18:31:34.288Z","sourceHash":"04f75ff6eebec70ebd15f157502b7c04b5ba291c00be05f07b05087ccb13186c","companyId":"c6f40f74-5248-4720-8404-fd1e03022e90","foundedYear":null,"logoUrl":null,"path":"/news/48c7fbb5-da1d-4d8f-8891-16287b8388df"}],"path":"/institutions/UB-I8645","canonical":"https://uniquebase.ai/institutions/UB-I8645"}